- $11.26m
- $11.39m
- $17.77m
Annual income statement for Cycurion, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2023 December 31st | 2024 December 31st | |
|---|---|---|
| Period Length: | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS |
| Standards: | USG | USG |
| Status: | Final | Final |
| Revenue | ||
| Total Revenue | 19.4 | 17.8 |
| Cost of Revenue | ||
| Gross Profit | 2.64 | 3.63 |
| Selling / General / Administrative Expenses | ||
| Total Operating Expenses | 19 | 15.4 |
| Operating Profit | 0.326 | 2.42 |
| Total Net Non Operating Interest Income / Expense | ||
| Other Net Non Operating Costs | ||
| Net Income Before Taxes | -2.09 | 1.23 |
| Provision for Income Taxes | ||
| Net Income After Taxes | -2.1 | 1.23 |
| Net Income Before Extraordinary Items | ||
| Net Income | -2.1 | 1.23 |
| Income Available to Common Shareholders Excluding Extraordinary Items | ||
| Income Available to Common Shareholders Including Extraordinary Items | ||
| Diluted Net Income | -2.1 | 1.23 |
| Diluted Weighted Average Shares | ||
| Basic EPS Including Extraordinary Items | ||
| Diluted EPS Including Extraordinary Items | ||
| Diluted EPS Excluding Extraordinary Items | ||
| Normalised Income Before Taxes | ||
| Normalised Income After Taxes | ||
| Normalised Income Available to Common Shareholders | ||
| Diluted Normalised EPS | -5.3 | 3.11 |